Amplifon のニュースと活動

Amplifonはの一部です...

• Stoxx 600;
• TOB Iconic 10,000.

％sは、株式相場表示 ％s（％s）の下にリストされている会社です。

Amplifon は 11 の国に直接拠点を置いています。

AmplifonはAmplifon Americas,Amplifon Australia,Amplifon Belgiumを含む11の子会社があります。

Amplifon を含む合併、買収、資金調達。

• Amplifon has announced the acquisition of GN Hearing  (2026年3月25日に公開).

89人の主要幹部と一緒に組織図を見る

Amplifonでもっとも検索された略歴

• Enrico Vita, Chief Executive Officer and Director
• Susan Holland, Chairwoman of the Board
• Maurizio Costa, Independent Director

アラートを作成
Amplifon のエグゼクティブの異動をフォローします。

AmplifonはThermo Fisher Scientific (アメリカ合衆国（米国）),Medtronic (アイルランド),Philips (オランダ王国)を含む1,235の競合企業を有します。

Popular M&A news in 医療機器

• Bridgepoint has announced the acquisition of Obagi Medical Products  (2026年6月4日に公開).
• ％sは、％s百万ドルの資金調達を発表しました。 (2026年6月2日に公開).
• Edap Tms将改名为FocalTherics。 (2026年6月1日に公開).

医療機器業界でのその他のコンタクトの提案

• Medtronic 社 Kweli Thompson - Executive Vice President and President, Neuroscience Portfolio
• Zimmer Biomet 社 Ivan Tornos - Chairman, President and Chief Executive Officer
• Illumina 社 Jacob Thaysen - Chief Executive Officer and Director

医療機器業界についてさらに知る

％sによる最新のプレスリリース

• Successful completion of the placement reserved to qualified investors by means of an accelerated bookbuild offering with a book multiple times oversubscribed | Amplifon Corporate
• Publication of the updated Articles of Association | Amplifon Corporate
• Notice of change in share capital. Filing of certification pursuant to article 2444 of the Italian civil code | Amplifon Corporate
• Resolved a share capital increase for the issue of a maximum no. of 45,300,000 new ordinary shares to be offered for subscription through a private placement reserved to qualified investors. Private placement launched through an accelerated bookbuilding
• Amplifon signs agreement to sell its Indian activities to Hearzap | Amplifon Corporate
• Publication of the minutes of the Ordinary Shareholders’ Meeting held on April 23, 2026 | Amplifon Corporate
• Announcement regarding voting rights (art. 85-bis paragraph 4-bis of Issuers’ Regulation) | Amplifon Corporate
• Significant acceleration in organic growth (+2.2%), revenues at 580 million euros and record adjusted EBITDA margin at 24.5% (+60 bps) in the first quarter of 2026, thanks to last year’s initiatives and investments | Amplifon Corporate
• The Shareholders’ Meeting approved the 2025 Financial Statements | Amplifon Corporate
• Announcement regarding voting rights (art. 85-bis paragraph 4-bis of Issuers’ Regulation and art. 2.6.2. paragraph 1 part a) of Borsa Italiana S.p.A. markets rules) | Amplifon Corporate
• View more press releases Close

％sについてのソーシャルメディア

• Amplifon についてのウィキペディア,Google News & Yahoo Financeの記事
• Amplifon についてのLinkedIn,ツイッター & YouTubeの記事